Share your insights

Help us by sharing what content you've recieved in your exams


Viral hepatitis

Background knowledge 🧠

Definition

  • Viral hepatitis is an inflammation of the liverΒ caused by a viral infection.
  • Commonly caused by hepatitis A, B, C, D, and E viruses.
  • Can lead to both acuteΒ and chronic liver disease.

Epidemiology

  • Hepatitis B and C are the most common causes of chronic viral hepatitis globally.
  • Hepatitis A and E are typically self-limiting and more common in regions with poor sanitation.
  • Hepatitis B is highly endemic in sub-Saharan Africa and East Asia.
  • Hepatitis C is prevalent among intravenous drug usersΒ and in countries with low medical safety standards.
  • Hepatitis D requires the presence of hepatitis B and is seen in areas where hepatitis B is common.

Aetiology and pathophysiology

  • Hepatitis A and E: Faecal-oral transmission, often due to contaminated food or water.
  • Hepatitis B, C, and D: Bloodborne transmission (e.g., needle sharing, blood transfusions, sexual contact).
  • Chronic infection with hepatitis B and C can lead to cirrhosis and hepatocellular carcinoma.
  • Hepatitis D causes more severe disease when co-infected with hepatitis B.
  • Pathophysiology involves immune-mediated liver cell injury.

Types

  • Hepatitis A: Acute, self-limiting; no chronic stage.
  • Hepatitis B: Can be acute or chronic; chronic infection can lead to severe liver disease.
  • Hepatitis C: Often asymptomaticΒ in acute phase;Β chronic infection is common and can lead to liver cirrhosis.
  • Hepatitis D: Requires hepatitis B co-infection;Β increases severity of hepatitis B.
  • Hepatitis E: Similar to hepatitis A; usually self-limiting but can be severe in pregnant women.

Clinical Features 🌑️

Symptoms

  • Fatigue, malaise.
  • Nausea, vomiting.
  • Loss of appetite.
  • Abdominal pain, particularly in the right upper quadrant.
  • Jaundice (especially in hepatitis A and E).

Signs

  • Jaundice: Yellowing of skin and sclera.
  • Hepatomegaly: Enlarged liver on palpation.
  • Dark urine and pale stools.
  • Pruritus (especially in cholestatic hepatitis).
  • Spider naevi and palmar erythema (in chronic hepatitis).
  • Signs of decompensated liver disease in advanced chronic hepatitis: ascites, encephalopathy.

Investigations πŸ§ͺ

Tests

  • Liver function tests (LFTs): Elevated ALT and AST.
  • Viral serologies: Hepatitis A IgM, Hepatitis B surface antigen (HBsAg), Hepatitis C antibody.
  • PCR for viral RNA/DNA (e.g., HCV RNA, HBV DNA).
  • Ultrasound: Assess liver size, rule out biliary obstruction.
  • Liver biopsy: If diagnosis is uncertain or to assess fibrosis in chronic hepatitis.

Management πŸ₯Ό

Management

  • Hepatitis A and E: Supportive care; hydration, avoid hepatotoxic drugs.
  • Hepatitis B: Antiviral therapy (e.g., tenofovir, entecavir) in chronic cases or severe acute cases.
  • Hepatitis C: Direct-acting antivirals (e.g., sofosbuvir, ledipasvir) for chronic infection.
  • Hepatitis D: Pegylated interferon in chronic cases; no specific antiviral therapy available.
  • Vaccination: Hepatitis A and B vaccinesΒ available; no vaccine for hepatitis C.
  • Liver transplantation: In cases of fulminant hepatitis or end-stage liver disease.

Complications

  • Chronic hepatitis (B and C) can lead to cirrhosis.
  • Increased risk of hepatocellular carcinoma in chronic hepatitis B and C.
  • Fulminant hepatitis: Acute liver failure with high mortality.
  • Co-infection with HIV increases morbidity and mortality.
  • Autoimmune hepatitis may be triggered by viral hepatitis.

Prognosis

  • Hepatitis A and E: Excellent prognosis; full recovery in most cases.
  • Hepatitis B: Variable prognosis; chronic infection in 5-10% of adults.
  • Hepatitis C: High rate of chronicity; cirrhosis and liver cancer in untreated cases.
  • Hepatitis D: Poorer prognosis due to more severe liver disease.
  • Complications lead to increased mortality and morbidity.

Key points

  • Vaccination is crucial in preventing hepatitis A and B.
  • Early detection and treatment of hepatitis B and C can prevent severe complications.
  • Public health measures are vital to control the spread of viral hepatitis.
  • Multidisciplinary care is often required for managing chronic hepatitis.

No comments yet πŸ˜‰

Leave a Reply